TRML
NASDAQ:TRML
Tourmaline Bio, Inc.
- Stock
locale
United States
market
STOCKSindustry
Biotechnologywebsite
www.tourmalinebio.comipo date
May 07, 2021
Tourmaline Bio, Inc. operates as a clinical biotechnology company that develops medicines for patients with life-altering immune diseases. It develops medicines and therapies for the Atherosclerotic cardiovascular disease (ASCVD) and Thyroid Eye Disease (TED). The company was incorporated in 2021 and is based in New York, New York.